Condorcet Global Opportunity Fund’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Condorcet Global Opportunity Fund’s Portfolio CBST Stock Details CBST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$8.47M	Buy	+84,204	New	+$6.55M	3.5%	10

Other funds holding CBST

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Condorcet Global Opportunity Fund's CBST Position: Q4 2014 in Review

Condorcet Global Opportunity Fund opened a new position in CUBIST PHARMACEUTICALS INC (CBST) in Q4 2014: 84,204 shares worth $8.47M. The stake represents 3.5% of the portfolio and ranks #10 among its holdings.

307 funds tracked by Wall St. Rank hold CBST as of Q4 2014.

Condorcet Global Opportunity Fund held 84,204 shares of CUBIST PHARMACEUTICALS INC worth $8.47M as of Q4 2014.
CUBIST PHARMACEUTICALS INC was a new Condorcet Global Opportunity Fund position in Q4 2014.
CUBIST PHARMACEUTICALS INC made up 3.5% of Condorcet Global Opportunity Fund's portfolio in Q4 2014, its #10 holding.
307 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q4 2014.

Based on Condorcet Global Opportunity Fund's 13F filing for Q4 2014, filed 17 Feb 2015.